9-68537443-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153237.2(TMEM252):āc.329A>Cā(p.Gln110Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,604,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_153237.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM252 | NM_153237.2 | c.329A>C | p.Gln110Pro | missense_variant | 2/2 | ENST00000377311.4 | NP_694969.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM252 | ENST00000377311.4 | c.329A>C | p.Gln110Pro | missense_variant | 2/2 | 1 | NM_153237.2 | ENSP00000366528 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000920 AC: 22AN: 239084Hom.: 0 AF XY: 0.0000695 AC XY: 9AN XY: 129508
GnomAD4 exome AF: 0.000169 AC: 245AN: 1452182Hom.: 0 Cov.: 31 AF XY: 0.000162 AC XY: 117AN XY: 722380
GnomAD4 genome AF: 0.000105 AC: 16AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.329A>C (p.Q110P) alteration is located in exon 2 (coding exon 2) of the TMEM252 gene. This alteration results from a A to C substitution at nucleotide position 329, causing the glutamine (Q) at amino acid position 110 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at